Market News

Technology

STOCKS

Moderna Announces mRNA-1345 Phase 3 Results

Moderna Announces mRNA-1345 Phase 3 Results

Moderna, Inc. (NASDAQ: MRNA) has announced positive data from its ConquerRSV Phase 3 trial of mRNA-1345, an investigational mRNA vaccine that targets respiratory syncytial virus in older adults. Following review by an independent Data and Safety Monitoring Board...

read more

ENERGY

Videos

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

FOLLOW US

NEWEST

COMMODITIES

LIVE FOREX RATES